New Haven [US], June 6 (ANI): Patients with advanced pancreatic neuroendocrine tumours (NETs) have few treatment options, but researchers at Yale Cancer Center and Yale-New Haven Health's Smilow Cancer Hospital discovered that patients who received a combination of capecitabine and temozolomide had a higher progression-free survival rate than those who received temozolomide alone.
Washington [US], September 3 (ANI): In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters. Targeting these T cells, which are a type of white blood cells, with immunotherapy drugs could increase the number of cancer patients that respond to treatment.
\
\
\
\
